1-3 of 3
Andrew M. Tershakovec
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial

Open Access
John R. Guyton, MD, Sergio Fazio, MD, Adeniyi J. Adewale, PHD, Erin Jensen, MS, Joanne E. Tomassini, PHD, Arvind Shah, PHD, Andrew M. Tershakovec, MD
Journal: Diabetes Care
Diabetes Care 2012;35(4):857–860
https://doi.org/10.2337/dc11-1369
Published: 13 March 2012
View articletitled, Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial
Open the PDF for Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia

Open Access
Ronald B. Goldberg, MD, John R. Guyton, MD, Theodore Mazzone, MD, Ruth S. Weinstock, MD, PHD, Adam B. Polis, MA, Diane Tipping, MS, Joanne E. Tomassini, PHD, Andrew M. Tershakovec, MD, MPH
Journal: Diabetes Care
Diabetes Care 2010;33(5):1021–1024
https://doi.org/10.2337/dc09-1762
Published: 11 February 2010
View articletitled, Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia
Open the PDF for Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia in another window
Includes: Supplementary data
Journal Articles

Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study

Free
Andrew M. Tershakovec, MD, William F. Keane, MD, Zhongxin Zhang, PHD, Paulette A. Lyle, BS, Gerald B. Appel, MD, Janet B. McGill, MD, Hans-Henrik Parving, MD, Mark E. Cooper, MD, PHD, Shahnaz Shahinfar, MD, Barry M. Brenner, MD
Journal: Diabetes Care
Diabetes Care 2008;31(3):445–447
https://doi.org/10.2337/dc07-0196
Published: 01 March 2008
View articletitled, Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study
Open the PDF for Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study in another window